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Do guidelines for treating
chest disease in children use
Cochrane Reviews effectively?
A systematic review
ABSTRACT
Cochrane Reviews summarise best evidence
and should inform guidelines. We assessed
the use of Cochrane Reviews in the UK
guidelines for paediatric respiratory disease.
We found 21 guidelines which made 1025
recommendations, of which 96 could be
informed by a Cochrane Review. In 38/96
recommendations (40%), some or all of the
relevant Cochrane Reviews were not cited. We
linked recommendations to 140 Cochrane
Reviews. In 37/140 (26%) cases, the guideline
recommendation did not fully agree with the
Cochrane Review. Guideline developers may
fail to use Cochrane Reviews or may make
recommendations which are not in line with
best evidence.
INTRODUCTION
Clinical practice guidelines support optimal
decision making in medical care. Guidelines
should use the best available evidence.1
Systematic reviews use transparent criteria
(such as Grading of Recommendations
Assessment, Development and Evaluation
(GRADE)) to evaluate the quality of evi-
dence2 and so systematic reviews (where
available) should be the primary source of
evidence in guidelines. The Cochrane
Collaboration produces systematic reviews
(‘Cochrane Reviews’) using a rigorous meth-
odology. These are peer reviewed at the
protocol and review stage, and are updated
regularly.3 Previous work indicates that
guidelines do not make full use of Cochrane
Reviews.4 5 This represents research
wastage, and may lead to suboptimal
medical care.
Respiratory disease in children is
common—20% of children visiting the
emergency department, with a medical
problem, will have a respiratory illness.6
However, the paediatric respiratory evi-
dence base is limited. Nearly half of chil-
dren with respiratory disease receive a
medication which is off-label or
unlicensed.7 It is particularly important
that guidelines for respiratory disease in
children make the best use of this limited
evidence. We examined the use of evi-
dence from Cochrane Reviews in guide-
lines for respiratory disease in children.
We aimed to understand the use of the
best available evidence in the ﬁeld of
paediatric respiratory medicine. We sys-
tematically examined the use of Cochrane
Reviews in the UK clinical guidelines for
lower respiratory diseases in children and
we examined the agreement between
the guideline recommendations and the
Cochrane Reviews. We investigated the
association between guideline commission-
ing agency, the topic, the publication year
and the use of alternate high-quality evi-
dence on whether Cochrane Reviews were
cited, and whether their conclusions were
followed.
METHODS
We identiﬁed all the respiratory guidelines
in the UK for lower respiratory tract disease
for children via database and web searches.
We simultaneously identiﬁed all the
Cochrane Reviews relevant to paediatric
respiratory medicine, via the Cochrane
library. For each guideline, we included all
recommendations pertaining to an inter-
vention for lower respiratory tract disease
in children. For each recommendation, we
identiﬁed if there was a Cochrane Review
which could inform it, and which had been
published at least 1 year prior to the guide-
line. We mapped each guideline recommen-
dation to relevant Cochrane Reviews.
For each linked guideline recommenda-
tion—Cochrane Review, we categorised
the agreement between the guideline rec-
ommendation and the Cochrane Review
into one of four categories: (i) totally, (ii)
partially, (iii) not in agreement or (iv) a
strong guideline recommendation where
the Cochrane Review concluded that
there was not enough evidence to draw a
conclusion (see online supplementary
tables S1 and S2 for deﬁnitions and exam-
ples). Where guideline recommendations
disagreed with the Cochrane Review, we
categorised the extent of the disagreement.
The protocol (including study eligibility
criteria and statistical analysis plan) was
produced in advance of the data collection,
is available at the University of
Nottingham ePrints server and as online
supplementary ﬁles 2 and 3). Detailed
methods are provided in online
supplementary information.
RESULTS
Guidelines and Cochrane Reviews
identiﬁed
We included 21 guidelines and 236
Cochrane Reviews (see ﬁgure 1). The 21
guidelines made 1025 recommendations,
of which 555 were for treatment of lower
respiratory disease in children. We identi-
ﬁed relevant Cochrane Reviews for 96
(17.3%) of these 555 recommendations.
Of the 96 recommendations that could
use Cochrane Reviews, 28/96 (29%) did
not use any, and 10/96 (10%) did not use
all the available Cochrane Reviews. There
were 140 instances where a Cochrane
Review could be linked to at least one
guideline recommendation. Of these, 103/
140 (74%) were in agreement, 13/140
(9%) were partially in agreement, 5/140
(4%) disagreed and 19/140 (13%) were
strong recommendations but the Cochrane
Review did not draw a conclusion. Few
Cochrane Reviews in paediatric respiratory
medicine were able to draw a strong con-
clusion, 96/283 (34%).
We summarise these data in ﬁgure 2. An
interactive version of this ﬁgure allowing the
reader to directly explore the data within a
web browser is available online here: https://
www.nottingham.ac.uk/~mszap3/interactive_
ﬁgure.html.
Further analysis is presented in the
online supplementary information, includ-
ing a sensitivity analysis of our judgements
in categorising agreement and an analysis
investigating the impact of commissioning
agency, guideline topic, guideline year and
guideline use of alternate high-quality evi-
dence on the use of Cochrane Reviews.
DISCUSSION
We found that 38/96 (40%) of guideline
recommendations did not use all the rele-
vant Cochrane Reviews. The majority of
guideline recommendations were in agree-
ment with Cochrane Review recommen-
dations. We present the data as an
interactive ﬁgure allowing the reader to
explore the links between Cochrane
Reviews and guideline recommendations.
Our results are broadly in keeping with
studies in other ﬁelds such as smoking ces-
sation and neonatal medicine which show
that guidelines do not make the best use
of Cochrane Reviews. Silagy et al4 found
four guidelines for smoking cessation (one
from the UK). In the UK guideline, 16/22
recommendations could have cited a
Cochrane Review but only 8 recommenda-
tions did so. Brok et al5 studied the agree-
ment between guidelines and Cochrane
Reviews for newborns in Denmark.
Compared with our study, they found
similar discrepancies between Cochrane
Reviews and guideline recommendations
—24% were not in agreement (of which
6% partially agreed and 18% disagreed).
Our study is comprehensive, used an a
priori protocol and categorisations were
conducted independently by two investi-
gators. The study has limitations, includ-
ing the subjectivity in decisions regarding
agreement and disagreement. We expand
on this in online supplementary ﬁle 1.
CONCLUSION
In spite of the work of the Cochrane col-
laboration, there are still many treatment
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Figure 1 Flow diagram of the selection of guidelines and Cochrane Reviews.
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Figure 2 Do Cochrane Reviews inﬂuence clinical practice guideline recommendations? Evidence network diagram to show the links between
Cochrane Reviews and Guideline recommendations. Each individual guideline recommendation is represented by a purple node, and each Cochrane
Review by a green node. A solid blue line connecting a guideline recommendation to a Cochrane recommendation indicates that the guideline cited
the Cochrane Review, and the two are in agreement. A broken line indicates that the guideline did not cite the Cochrane Review. A brown line
indicates that the Cochrane Review and guideline were not totally in agreement. Panel A shows all the links. Subsequent panels are subgrouped by
disease topic: B=asthma, C=cystic ﬁbrosis, D=respiratory infections and E=respiratory aspects of critical care. An interactive web-based version of
the evidence network diagram (which loads in all recent major browsers) is available at www.nottingham.ac.uk/~mszap3/interactive_ﬁgure.html and
allows the reader to explore the underlying data further.
Thorax Month 2017 Vol 0 No 0 3
Research letter
group.bmj.com on July 14, 2017 - Published by http://thorax.bmj.com/Downloaded from 
decisions where there is no systematic
review to inform guideline recommenda-
tions. However, we have shown that, even
where a Cochrane Reviews exists, guideline
developers may not make use of it or may
make recommendations contrary to the
ﬁndings of the review. This study demon-
strates that only a minority of recommen-
dations in clinical practice guidelines are
based on the highest quality evidence. A
great deal of money, time and effort goes
into creating and updating Cochrane
Reviews. Not using such evidence in guide-
lines constitutes research waste.
Andrew P Prayle,1 Tessy Cox,1 Sherie J Smith,1
Joanne Rycroft-Malone,2 Kim S Thomas,3
Dyfrig A Hughes,4 Alan R Smyth1
1Division of Child Health, Obstetrics and Gynaecology,
University of Nottingham, Nottingham, UK
2School of Healthcare Sciences, Bangor University,
Bangor, UK
3Centre of Evidence Based Dermatology, University of
Nottingham, Nottingham, UK
4Centre for Health Economics and Medicines
Evaluation, Bangor University, Bangor, UK
Correspondence to Professor Alan R Smyth, Division
of Child Health, Obstetrics and Gynaecology, University
of Nottingham, E Floor East Block, Queens Medical
Centre, Derby Road, Nottingham NG7 2UH, UK; alan.
smyth@nottingham.ac.uk
Author note The protocol is available for this study at
http://eprints.nottingham.ac.uk/3031/ (part 1) and
http://eprints.nottingham.ac.uk/3032/ (part 2).
Twitter Follow Andrew Prayle @andrewprayle and
Alan R Smyth @AlanRSmyth
Acknowledgements The authors thank all those
who were involved in the development and authorship of
the Cochrane Reviews and Guidelines used within this
study.
Contributors The study was conceived by ARS, with
development by APP and TC. Final study design was
achieved by discussion of all authors. Data collection
and analysis: TC, APP and SJS. Data analysis, statistics
and programming: APP. Final manuscript written and
approved by all authors.
Funding This work did not receive speciﬁc funding.
APP was funded by a NIHR Doctoral Research
Fellowship (DRF-2009-02-112), and is currently funded
by a NIHR ACL post. DAH receives ﬁnancial support
from the MRC North West Hub in Trial Methodological
Research: MR/K025635/1. The funders and sponsor
had no involvement in the decision to publish, or the
contents of the publication. This report presents
independent research funded by the National Institute
for Health Research.
Competing interests All authors have completed the
Uniﬁed Competing Interests form at http://www.icmje.
org/coi_disclosure.pdf (available on request from the
corresponding author) and declare: no support from
any organisation for the submitted work; no ﬁnancial
relationships with any organisations that might have an
interest in the submitted work in the previous 3 years,
no other relationships or activities that could appear to
have inﬂuenced the submitted work. Professor Smyth
reports personal fees from Vertex, personal fees from
Gilead, personal fees from Roche, personal fees from
PTC Therapeutics, outside the submitted work. In
addition, Professor Smyth has a patent Alkyl
Quinolones as Biomarkers of Pseudomonas aeruginosa
Infection and Uses Thereof issued.
Provenance and peer review Not commissioned;
externally peer reviewed.
Data sharing statement The raw data and
computer code underlying this study to fully reproduce
all the statistics and ﬁgures reported are available as a
downloadable online supplementary ﬁle on GitHub
https://github.com/andrewprayle/Do-guidelines-for-
treating-chest-disease-in-children-use-Cochrane-
reviews-effectively.
▸ Additional material is published online only. To view
please visit the journal online (http://dx.doi.org/10.
1136/thoraxjnl-2016-208790).
Open Access This is an Open Access article
distributed in accordance with the terms of the Creative
Commons Attribution (CC BY 4.0) license, which
permits others to distribute, remix, adapt and build
upon this work, for commercial use, provided the
original work is properly cited. See: http://
creativecommons.org/licenses/by/4.0/
To cite Prayle AP, Cox T, Smith SJ, et al. Thorax
Published Online First: [please include Day Month Year]
doi:10.1136/thoraxjnl-2016-208790
Received 19 April 2016
Revised 1 March 2017
Accepted 5 March 2017
Thorax 2017;0:1–4.
doi:10.1136/thoraxjnl-2016-208790
REFERENCES
1 Shekelle PG, Woolf SH, Eccles M, et al. Developing
guidelines. BMJ 1999;318:593–6.
2 Guyatt GH, Oxman AD, Kunz R, et al. What is
“quality of evidence” and why is it important to
clinicians? BMJ 2008;336:995–8.
3 Delaney A, Bagshaw SM, Ferland A, et al. The quality
of reports of critical care meta-analyses in the
Cochrane database of systematic reviews: an
independent appraisal. Crit Care Med
2007;35:589–94.
4 Silagy CA, Stead LF, Lancaster T. Use of
systematic reviews in clinical practice guidelines:
case study of smoking cessation. BMJ
2001;323:833–6.
5 Brok J, Greisen G, Madsen LP, et al. Agreement
between Cochrane Neonatal reviews and clinical
practice guidelines for newborns in Denmark: a
cross-sectional study. Arch Dis Child Fetal Neonatal Ed
2008;93:F225–9.
6 Sands R, Shanmugavadivel D, Stephenson T, et al.
Medical problems presenting to paediatric emergency
departments: 10 years on. Emerg Med J
2012;29:379–82.
7 ’t Jong GW, Eland IA, Sturkenboom MC, et al.
Unlicensed and off-label prescription of
respiratory drugs to children. Eur Respir J
2004;23:310–13.
4 Thorax Month 2017 Vol 0 No 0
Research letter
group.bmj.com on July 14, 2017 - Published by http://thorax.bmj.com/Downloaded from 
A systematic review
children use Cochrane Reviews effectively? 
Do guidelines for treating chest disease in
Kim S Thomas, Dyfrig A Hughes and Alan R Smyth
Andrew P Prayle, Tessy Cox, Sherie J Smith, Joanne Rycroft-Malone,
 published online April 26, 2017Thorax 
 0
http://thorax.bmj.com/content/early/2017/04/26/thoraxjnl-2016-20879
Updated information and services can be found at: 
These include:
References
 #BIBL0
http://thorax.bmj.com/content/early/2017/04/26/thoraxjnl-2016-20879
This article cites 7 articles, 6 of which you can access for free at: 
Open Access
http://creativecommons.org/licenses/by/4.0/
use, provided the original work is properly cited. See: 
others to distribute, remix, adapt and build upon this work, for commercial
the Creative Commons Attribution (CC BY 4.0) license, which permits 
This is an Open Access article distributed in accordance with the terms of
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic Articles on similar topics can be found in the following collections 
 (251)Open access
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on July 14, 2017 - Published by http://thorax.bmj.com/Downloaded from 
